# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-016151
Filing Date
2022-03-30
Accepted
2022-03-30 16:06:48
Documents
75
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2021_chinapharma.htm iXBRL | 10-K | 1048709
2 | DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE EXCHANGE ACT | f10k2021ex4-2_chinapharma.htm | EX-4.2 | 18824
3 | LOANS EXTENSION CONFIRMATION LETTER, DATED DECEMBER 31, 2021, BETWEEN THE COMPAN | f10k2021ex10-11_chinapharma.htm | EX-10.11 | 3176
4 | CONSENT OF THE INDEPENDENT ACCOUNTING FIRM | f10k2021ex23-1_chinapharma.htm | EX-23.1 | 2998
5 | CERTIFICATION | f10k2021ex31-1_chinapharma.htm | EX-31.1 | 10760
6 | CERTIFICATION | f10k2021ex31-2_chinapharma.htm | EX-31.2 | 11274
7 | CERTIFICATION | f10k2021ex32-1_chinapharma.htm | EX-32.1 | 6068
8 | GRAPHIC | image_001.jpg | GRAPHIC | 14163
| Complete submission text file | 0001213900-22-016151.txt |  | 4904614

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | cphi-20211231.xsd | EX-101.SCH | 54608
10 | XBRL CALCULATION FILE | cphi-20211231_cal.xml | EX-101.CAL | 38217
11 | XBRL DEFINITION FILE | cphi-20211231_def.xml | EX-101.DEF | 239614
12 | XBRL LABEL FILE | cphi-20211231_lab.xml | EX-101.LAB | 467843
13 | XBRL PRESENTATION FILE | cphi-20211231_pre.xml | EX-101.PRE | 249161
69 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2021_chinapharma_htm.xml | XML | 368480

Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34471 | Film No.: 22786455
SIC: 2834 Pharmaceutical Preparations